| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Imatinib | Imatinib Carboxylic Impurity | VE009042 | View CAS 106261-49-8 |
| Imatinib | Imatinib EP Impurity A | VL272007 | View CAS 55314-16-4 |
| Imatinib | Imatinib EP Impurity B | VL272003 | View CAS 581076-65-5 |
| Imatinib | Imatinib EP Impurity B(HCl Salt) | VE008330 | View CAS 581076-67-7 |
| Imatinib | Imatinib EP Impurity C (HCl Salt) | VE008632 | View CAS 1820893-54-6 |
| Imatinib | Imatinib EP Impurity D | VL272002 | View CAS 1821122-73-9 |
| Imatinib | Imatinib EP Impurity F | VL272008 | View CAS 152460-10-1 |
| Imatinib | Imatinib EP Impurity H | VL272005 | View CAS 350-03-08 |
| Imatinib | Imatinib EP impurity C | VL272004 | View CAS 404844-02-6 |
| Imatinib | Imatinib Impurity 3 | VL272006 | View CAS 152459-96-6 |
| Imatinib | Imatinib Impurity J | VL272009 | View CAS 571186-91-9 |
| Imatinib | Imatinib N-Acetyl Impurity | VE009742 | View CAS 1321600-78-5 |
| Imatinib | Imatinib Piperazine-N, N-DiOxide | VE006650 | View CAS 571186-93-1 |
| Imatinib | Imatinib pyridine N oxide Impurity | VL272010 | View CAS 571186-92-0 |
| Dacarbazine | Imatinib | Metformin | Metformin EP Impurity F | VL101006 | View CAS 506-59-2 |
